Product: MMP7 Antibody
Catalog: AF0218
Description: Rabbit polyclonal antibody to MMP7
Application: WB IHC IF/ICC
Reactivity: Human, Mouse, Rat
Prediction: Pig, Sheep, Rabbit
Mol.Wt.: 29kDa; 30kD(Calculated).
Uniprot: P09237
RRID: AB_2833348

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:500-1:3000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human,Mouse,Rat
Prediction:
Pig(94%), Sheep(83%), Rabbit(83%)
Clonality:
Polyclonal
Specificity:
MMP7 Antibody detects endogenous levels of total MMP7.
RRID:
AB_2833348
Cite Format: Affinity Biosciences Cat# AF0218, RRID:AB_2833348.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

Matrilysin; Matrin; Matrix Metalloproteinase 7; Matrix metalloproteinase-7; MMP 7; MMP-7; MMP7; MMP7_HUMAN; MPSL1; PUMP 1; Pump 1 protease; Pump-1 protease; PUMP1; Uterine matrilysin; Uterine metalloproteinase;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Description:
MMP7 Degrades casein, gelatins of types I, III, IV, and V, and fibronectin. Activates procollagenase. Belongs to the peptidase M10A family. Note: This description may include information from UniProtKB.
Sequence:
MRLTVLCAVCLLPGSLALPLPQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIEIMQKPRCGVPDVAEYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHELGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK

Predictions

Predictions:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Pig
94
Sheep
83
Rabbit
83
Bovine
78
Dog
75
Chicken
71
Xenopus
59
Horse
0
Zebrafish
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - P09237 As Substrate

Site PTM Type Enzyme
S47 Phosphorylation
T49 Phosphorylation
K84 Acetylation

Research Backgrounds

Function:

Degrades casein, gelatins of types I, III, IV, and V, and fibronectin. Activates procollagenase.

Subcellular Location:

Secreted>Extracellular space>Extracellular matrix.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Family&Domains:

The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.

Belongs to the peptidase M10A family.

Research Fields

· Environmental Information Processing > Signal transduction > Wnt signaling pathway.   (View pathway)

References

1). Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids. Cellular & molecular immunology, 2022 (PubMed: 35039632) [IF=24.1]

2). Echinatin inhibits the growth and metastasis of human osteosarcoma cells through Wnt/β-catenin and p38 signaling pathways. Pharmacological Research, 2023 (PubMed: 37023991) [IF=9.3]

Application: WB    Species: Human    Sample: OS cells

Fig. 4. Ecn inhibits the migration and invasion of OS cells. (A) The effect of Ecn on the migration of OS cells (Wound healing assay, 100 ×). (B) The effect of Ecn on the migration of OS cells (Transwell assay, 100 ×). (C) The effect of Ecn on the invasion of OS cells (Matrigel-coated Transwell assay, 100 ×). (D) The effect of Ecn on the protein level of MMP2, MMP7, MMP9, Snail, Vimentin, N-Cadherin and E-Cadherin in OS cells (Western blot). ##P 

3). SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma. Clinical Science, 2019 (PubMed: 31654063) [IF=6.0]

4). Casticin induces ferroptosis in human osteosarcoma cells through Fe2+ overload and ROS production mediated by HMOX1 and LC3-NCOA4. Biochemical pharmacology, 2024 (PubMed: 38852641) [IF=5.8]

5). Securinine inhibits the tumor growth of human bladder cancer cells by suppressing Wnt/β-catenin signaling pathway and activating p38 and JNK signaling pathways. Biochemical pharmacology, 2024 (PubMed: 38484850) [IF=5.8]

Application: WB    Species: Human    Sample: BC cells

Fig. 3. SEC suppresses the migration and invasion of BC cells. (A) The effect of SEC on the migration of BC cells (Wound healing assay, 100 × ). (B) The effect of SEC on the migration of BC cells (Transwell assay, 100 × ). (C) The effect of SEC on the invasion of BC cells (Matrigel-coated transwell assay, 100 × ). (D) The effect of SEC on the protein levels of EMT markers and MMPs of BC cells (Western blot). Data are shown as mean ± SD from three independent experiments.

6). MMP‐7 affects peritoneal ultrafiltration associated with elevated aquaporin‐1 expression via MAPK/ERK pathway in peritoneal mesothelial cells. Journal of Cellular and Molecular Medicine, 2021 (PubMed: 34117704) [IF=5.3]

Application: WB    Species: Human    Sample: peritoneal mesothelial cells

FIGURE 2 High glucose induced the expression of MMP‐7 in peritoneal mesothelial cells. (a, b) Peritoneal mesothelial cells were seeded in the 6‐well plate (1 × 106 cells/well) and then stimulated with different concentrations of glucose for 24 hours. The mRNA level of MMP‐7 was detected through quantitative RT‐PCR (a), the protein level of MMP‐7 in the cells was detected by Western blotting analysis (b), and the production of MMP‐7 in the culture medium was detected by ELISA (c). (d‐e) Cells were incubated in dialysate with 4.25% glucose for indicated time points. The mRNA level of MMP‐7 was detected through quantitative RT‐PCR (d), the protein level of MMP‐7 in the cells was detected by Western blotting analysis (e), and the production of MMP‐7 in the culture medium was detected by ELISA (F). *P < 0.05, **P < 0.01, one of the three independent experiments is shown

Application: IF/ICC    Species: Human    Sample: peritoneal mesothelial cells

FIGURE 3 Recombinant MMP‐7 protein up‐regulated cell volume and enhanced aquaporin‐1 expression in peritoneal mesothelial cells. The HMrSV5 cells were seeded in the 6‐well plate (1 × 106 cells/well). (a) Cells were stimulated with MMP‐7 protein for 12 hours, followed by incubating in normal saline (NS) or dialysate with 4.25% glucose for 1 minute. The cell diameter of peritoneal mesothelial cells was evaluated by the Scepter 2.0 cell counter. The changes of cell diameter after glucose stimulation, with or without MMP‐7 incubation, were calculated. (b, c) The cells were treated with 50 ng/ml MMP‐7 for different time points. The mRNA level of AQP‐1 was detected by quantitative RT‐PCR (b), and the protein levels of AQP‐1 were detected by Western blotting (c). (d, e) The cells were treated with different concentrations of MMP‐7 for different time points. The mRNA level of AQP‐1 was detected by quantitative RT‐PCR (d), and the protein levels of AQP‐1 were detected by Western blotting (e). (f) The cells were treated with indicated 50 ng/ml MMP‐7 for 12 hours. The cells were then permeabilized by Triton‐X 100, and immunofluorescence assay was used to detect the expression of AQP‐1 (red, with DAPI‐stained blue nuclei). (g, h) The cells were treated with the indicated 50 ng/ml MMP‐7 for 12 hours. The expression of AQP‐1 in the HMrSV5 cell membrane was evaluated by Western blotting (g) and immunofluorescence assay (H). *P < 0.05, **P < 0.01, one of the three independent experiments is shown

7). Targeted changes in blood lipids improves fibrosis in renal allografts. Lipids in health and disease, 2023 (PubMed: 38049842) [IF=4.5]

Application: IHC    Species: Rat    Sample: kidneys

Fig. 4 Supplementation of n-3 polyunsaturated fatty acids contributes to improved interstitial fibrosis in rat renal transplantation models. A Schematic view of the establishment of rat renal transplantation models and the dietary mode. B Fatty acid constitution of soybean oil feed (SbOF) and linseed oil feed (LOF). C Gross morphology of bilateral kidneys from SbOF and LOF rats. D, E Masson staining detected the fibrosis level of transplanted kidneys from SbOF and LOF diet rats. F HE staining in heart, liver, spleen, lung, and normal kidney tissues from SbOF and LOF diet rats. G, H IHC detected fibrosis markers in transplanted kidneys from SbOF and LOF diet rats. Significance was determined by Student’s t test.

8). The microRNA‑708‑5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma. Oncology Reports, 2020 (PubMed: 31894343) [IF=4.2]

Application: WB    Species: Human    Sample: OS cells

Figure 3. miR-708-5p suppresses epithelial-to-mesenchymal transition (EMT) of OS cells. (A) mRNA and (C, left column) protein levels of MMP2, MMP7, MMP9, N-cadherin, vimentin, E-cadherin and Snail after miR-708-5p overexpression (708-5p mimics) compared to the scramble negative control (NC mimic) in MG63 cells. (B) mRNA and (C, right column) protein levels of MMP2, MMP9, N-cadherin, vimentin, E-cadherin and Snail after miR-708-5p overexpression (708-5p mimics) compared to the scramble negative control (NC mimic) in SaOS-2 cells. Relative protein expression levels in (D) MG63 and (E) SaOS-2 cells. All data are presented as mean ± SD from at least three independent experiments. *P<0.05, **P<0.01, NC mimic vs. 708-5p mimic. OS, osteosarcoma; MMP, matrix metalloproteinase.

9). Auxiliary antitumor effects of fungal proteins from Hericium erinaceus by target on the gut microbiota. Journal of Food Science, 2020 (PubMed: 32460371) [IF=3.9]

Application: WB    Species: Mice    Sample: tumor tissues

Figure 12–Effects of fungal proteins extracted from Hericium erinaceus on tumor tissues in xenografted cancer mice. (A-H) is the QT-PCR analysis results of some key genes in the tumor tissues; (I) is the western bolting analysis results of some key proteins in the tumor tissues; (J) is the level of LPS in serum; (K) is the plasma concentration of 5-Fu. Animals were randomly divided into nine groups: control (no treatments), xenograft-only (Model), HEP-only (FP), pre-xenograft HEP (PN), pre-xenograft HEP+5-Fu (PF), HEP+5-Fu (NP), 5-Fu-only (NF), antibiotics+HEP+ 5-Fu (AP), and antibiotics+5-Fu (AF). Only the control and HEP-only groups had no xenografts. Values are expressed as means ± SDs (n = 8), #P < 0.05 compared with control group, ∗P < 0.05, ∗∗P < 0.01 compared with model group, indicates significant differences compared to the model group.

10). Downregulation of LncRNA Gas5 Inhibits Apoptosis and Inflammation after Spinal Cord Ischemia-Reperfusion in Rats. BRAIN RESEARCH BULLETIN, 2021 (PubMed: 33316370) [IF=3.8]

Load more

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.